SAN DIEGO, April 12, 2017 /PRNewswire/ -- NuVasive,
Inc. (NASDAQ: NUVA), a leading medical device company focused on
transforming spine surgery with minimally disruptive,
procedurally-integrated solutions, today announced it will showcase
the Company's LessRay® software technology at the International
Society for Advancement of Spine Surgery's (ISASS) 17th
annual conference held April 12-14,
2017 in Boca Raton,
Florida.
LessRay is a proprietary image enhancement technology that
improves low-quality, low-radiation images to look more like
conventional full-dose images without disrupting surgical workflow.
The software is designed to be integrated into current surgeon
workflow and utilizes an algorithm to drive image registration and
enable management of radiation exposure, while maintaining
high-quality, intra-operative images on existing C-Arm workflow
without loss of visual accuracy.
NuVasive ISASS17 Participation Details
NuVasive will showcase its technologies at NuVasive Booth
#400 on the ISASS exhibit floor.
The Company will host an industry lunch workshop featuring
Robert Isaacs, M.D. and LessRay on
April 12, 2017 from 12:00 p.m. to 1:30 p.m. at Room Royal 7.
Visit here for more details and the schedule of events.
About NuVasive
NuVasive,
Inc. (NASDAQ: NUVA) is a world leader in minimally invasive,
procedurally-integrated spine solutions. From complex spinal
deformity to degenerative spinal conditions, NuVasive is
transforming spine surgery with innovative technologies designed to
deliver reproducible and clinically proven surgical outcomes.
NuVasive's highly differentiated, procedurally-integrated solutions
include access instruments, implantable hardware and software
systems for surgical planning and reconciliation technology that
centers on achieving the global alignment of the spine. With
$962 million in revenues (2016),
NuVasive has an approximate 2,300 person workforce in more than 40
countries around the world. For more information, please visit
www.nuvasive.com.
Forward-Looking
Statements
NuVasive cautions you
that statements included in this news release that are not a
description of historical facts are forward-looking statements that
involve risks, uncertainties, assumptions and other factors which,
if they do not materialize or prove correct, could
cause NuVasive's results to
differ materially from historical results or those expressed or
implied by such forward-looking statements. The potential risks and
uncertainties which contribute to the uncertain nature of these
statements include, among others, risks associated with acceptance
of the Company's surgical products and procedures by spine
surgeons, development and acceptance of new products or product
enhancements, clinical and statistical verification of the benefits
achieved via the use of NuVasive's products
(including the iGA™ platform), the Company's ability to effectually
manage inventory as it continues to release new products, its
ability to recruit and retain management and key personnel, and the
other risks and uncertainties described
in NuVasive's news releases
and periodic filings with the Securities and
Exchange Commission. NuVasive's public filings
with the Securities and Exchange
Commission are available
at www.sec.gov. NuVasive assumes
no obligation to update any forward-looking statement to reflect
events or circumstances arising after the date on which it was
made.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nuvasive-to-feature-proprietary-radiation-reduction-platform-at-isass-2017-300438555.html
SOURCE NuVasive, Inc.